These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6980759

  • 1. Effect of ADA deficiency on cultured murine thymus transplantation.
    Hong R, Horowitz SD, Fortman C, Martin DW.
    Clin Immunol Immunopathol; 1982 May; 23(2):448-58. PubMed ID: 6980759
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
    Ratech H, Thorbecke GJ, Hirschhorn R.
    Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
    [No Abstract] [Full Text] [Related]

  • 3. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
    Goday A, Simmonds HA, Morris GS, Fairbanks LD.
    Biochem Pharmacol; 1985 Oct 01; 34(19):3561-9. PubMed ID: 3876835
    [Abstract] [Full Text] [Related]

  • 4. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
    Ratech H, Kim J, Asofsky R, Thorbecke GJ, Hirschhorn R.
    J Immunol; 1984 Jun 01; 132(6):3077-84. PubMed ID: 6202772
    [Abstract] [Full Text] [Related]

  • 5. Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.
    Ratech H, Hirschhorn R, Thorbecke GJ.
    Am J Pathol; 1985 Apr 01; 119(1):65-72. PubMed ID: 3872599
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
    Hirschhorn R, Ratech H.
    Curr Top Hematol; 1983 Apr 01; 4():1-35. PubMed ID: 6413135
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.
    Mitchell BS, Kelley WN.
    Ann Intern Med; 1980 Jun 01; 92(6):826-31. PubMed ID: 6247948
    [Abstract] [Full Text] [Related]

  • 14. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
    Thuillier L, Garreau F, Cartier PH.
    Eur J Immunol; 1981 Oct 01; 11(10):788-94. PubMed ID: 6975717
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interleukin 2 liberation and absorption capacities of rat T lymphocytes in conditions of severe adenylic nucleotide pool depletion due to adenosine deaminase deficiency.
    Thuillier L, Arenzana-Seisdedos F, Pérignon JL, Munier A, Hamet M, Cartier PH.
    Immunopharmacology; 1985 Oct 01; 10(2):89-97. PubMed ID: 3877709
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
    Grever MR, Siaw MF, Coleman MS, Whisler RL, Balcerzak SP.
    J Immunol; 1983 Jan 01; 130(1):365-9. PubMed ID: 6600187
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.